Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions.

Wu QJ, Wang Z, Kirkpatrick JP, Chang Z, Meyer JJ, Lu M, Huntzinger C, Yin FF.

Radiat Oncol. 2009 Jan 21;4:3. doi: 10.1186/1748-717X-4-3.

2.

Stereotactic body radiation therapy in multiple organ sites.

Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L.

J Clin Oncol. 2007 Mar 10;25(8):947-52. Review.

PMID:
17350943
3.

Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.

Kavanagh BD, Schefter TE, Cardenes HR, Stieber VW, Raben D, Timmerman RD, McCarter MD, Burri S, Nedzi LA, Sawyer TE, Gaspar LE.

Acta Oncol. 2006;45(7):848-55.

PMID:
16982549
4.

Stereotactic radiotherapy of primary liver cancer and hepatic metastases.

Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, Flentje M.

Acta Oncol. 2006;45(7):838-47.

PMID:
16982548
5.

Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.

Xia T, Li H, Sun Q, Wang Y, Fan N, Yu Y, Li P, Chang JY.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):117-25. Epub 2006 Jun 9.

PMID:
16765528
6.

Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients.

Nyman J, Johansson KA, Hultén U.

Lung Cancer. 2006 Jan;51(1):97-103. Epub 2005 Oct 4.

PMID:
16213059
7.

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.

Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N, Yano S, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1427-31. Epub 2005 Sep 19.

PMID:
16169670
8.

A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.

Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1371-8.

PMID:
16029795
9.

Dosimetric advantage and clinical implication of a micro-multileaf collimator in the treatment of prostate with intensity-modulated radiotherapy.

Wang L, Hoban P, Paskalev K, Yang J, Li J, Chen L, Xiong W, Ma CC.

Med Dosim. 2005 Summer;30(2):97-103.

PMID:
15922176
10.

Intensity modulated radiation therapy with multileaf collimators of different leaf widths: a comparison of achievable dose distributions.

Nill S, Tücking T, Münter MW, Oelfke U.

Radiother Oncol. 2005 Apr;75(1):106-11. Epub 2005 Apr 18.

PMID:
15878108
11.

Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.

Dvorak P, Georg D, Bogner J, Kroupa B, Dieckmann K, Pötter R.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1572-81.

PMID:
15817364
12.
13.

Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT.

Wang L, Movsas B, Jacob R, Fourkal E, Chen L, Price R, Feigenberg S, Konski A, Pollack A, Ma C.

J Appl Clin Med Phys. 2004 Spring;5(2):29-41. Epub 2004 Apr 1.

PMID:
15738911
14.

Effect of MLC leaf width on the planning and delivery of SMLC IMRT using the CORVUS inverse treatment planning system.

Burmeister J, McDermott PN, Bossenberger T, Ben-Josef E, Levin K, Forman JD.

Med Phys. 2004 Dec;31(12):3187-93.

PMID:
15651601
15.

American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy.

Potters L, Steinberg M, Rose C, Timmerman R, Ryu S, Hevezi JM, Welsh J, Mehta M, Larson DA, Janjan NA; American Society for Therapeutic Radiology and Oncology; American College of Radiology.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1026-32. No abstract available.

PMID:
15519771
16.

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.

Chang EL, Shiu AS, Lii MF, Rhines LD, Mendel E, Mahajan A, Weinberg JS, Mathews LA, Brown BW, Maor MH, Cox JD.

Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1288-94.

PMID:
15275711
17.

Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report.

Bilsky MH, Yamada Y, Yenice KM, Lovelock M, Hunt M, Gutin PH, Leibel SA.

Neurosurgery. 2004 Apr;54(4):823-30; discussion 830-1.

PMID:
15046647
18.

Extracranial stereotactic radioablation: physical principles.

Papiez L, Timmerman R, DesRosiers C, Randall M.

Acta Oncol. 2003;42(8):882-94.

PMID:
14968949
19.

Comparison of a micro-multileaf collimator with a 5-mm-leaf-width collimator for intracranial stereotactic radiotherapy.

Monk JE, Perks JR, Doughty D, Plowman PN.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1443-9.

PMID:
14630284
20.

Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis.

Ryu S, Fang Yin F, Rock J, Zhu J, Chu A, Kagan E, Rogers L, Ajlouni M, Rosenblum M, Kim JH.

Cancer. 2003 Apr 15;97(8):2013-8.

Items per page

Supplemental Content

Write to the Help Desk